Dihydromethysticin (Standard)

Overview

Dihydromethysticin (Standard) is the analytical standard of Dihydromethysticin ( HY-N0921 ). This product is intended for research and analytical applications. Dihydromethysticin is an orally active natural active ingredient. Dihydromethysticin can be extracted from Piper methysticum . Dihydromethysticin inhibits carboxylesterase 1 ( K i = 68.2 μM) and CYP2A5 . Dihydromethysticin upregulates NLRC3 and induces Apoptosis . Dihydromethysticin exhibits anticancer activity against colorectal cancer and lung adenoma.

Application

Products | Products > Disease Areas > Cancer | Products > Signaling Pathways > Others | Products > Signaling Pathways > Metabolic Enzyme/Protease | Products > Signaling Pathways > Immunology/Inflammation | Products > Signaling Pathways > Apoptosis | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Immunotherapy | Products > Research Areas > Cancer > Cancer Metabolism and Metastasis | Products > Signaling Pathways > Reference Standards | Products > Signaling Pathways > Carboxylesterase (CES) | Products > Signaling Pathways > NOD-like Receptor (NLR) | Products > Signaling Pathways > Apoptosis

Product Information

• Catalog No.: HY-N0921R
• CAS No.: 19902-91-1
• Molecular Formula: C15H16O5
• Molecular Weight: 276.28
• Purity: 99.98%
• Storage: Please store the product under the recommended conditions in the Certificate of Analysis.

Source

Original product source